- Home
- KZIA vs MNDR Comparison
KZIA vs MNDR Comparison
Compare KZIA & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- MNDR
- Stock Information
- Founded
- KZIA 1994
- MNDR 2016
- Country
- KZIA Australia
- MNDR Singapore
- Employees
- KZIA 7
- MNDR N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- MNDR
- Sector
- KZIA Health Care
- MNDR
- Exchange
- KZIA Nasdaq
- MNDR Nasdaq
- Market Cap
- KZIA 11.7M
- MNDR 9.3M
- IPO Year
- KZIA 1999
- MNDR 2024
- Fundamental
- Price
- KZIA $6.99
- MNDR $3.03
- Analyst Decision
- KZIA Strong Buy
- MNDR
- Analyst Count
- KZIA 3
- MNDR 0
- Target Price
- KZIA $16.00
- MNDR N/A
- AVG Volume (30 Days)
- KZIA 188.4K
- MNDR 73.0K
- Earning Date
- KZIA 11-14-2025
- MNDR 10-23-2025
- Dividend Yield
- KZIA N/A
- MNDR N/A
- EPS Growth
- KZIA N/A
- MNDR N/A
- EPS
- KZIA N/A
- MNDR N/A
- Revenue
- KZIA $1,549,158.00
- MNDR $11,600,567.00
- Revenue This Year
- KZIA N/A
- MNDR $188,831.77
- Revenue Next Year
- KZIA N/A
- MNDR $76.44
- P/E Ratio
- KZIA N/A
- MNDR N/A
- Revenue Growth
- KZIA 248983.08
- MNDR 0.61
- 52 Week Low
- KZIA $2.86
- MNDR $2.88
- 52 Week High
- KZIA $39.05
- MNDR $40.00
- Technical
- Relative Strength Index (RSI)
- KZIA 46.43
- MNDR 49.43
- Support Level
- KZIA $6.56
- MNDR $2.90
- Resistance Level
- KZIA $7.39
- MNDR $3.25
- Average True Range (ATR)
- KZIA 0.44
- MNDR 0.20
- MACD
- KZIA 0.02
- MNDR -0.17
- Stochastic Oscillator
- KZIA 29.55
- MNDR 10.25
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.